Healthy exports: Strong demand from abroad since the EU referendum supported revenue growth

Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry is an integral part of the pharmaceutical supply chain and the pharmaceutical sector’s research and development (R&D) process. There was a sharp decline in revenue over the first two years of the period, partly due to competition arising from growing pharmaceutical industries in developing countries, as well as the expiration of patent protection on multiple high turnover products. Rising demand for health care and an ageing population supported industry growth from 2016-17...read more.

Industry Statistics & Market Size
Revenue
£1.8bn
Annual Growth 15-20
6.3%
Forecast Growth 20-25
Profit
Employment
8,017
Businesses
191

Industry Threats & Opportunities

  • Strong export growth significantly boosted industry revenue at the end of the period
  • The weak pound supported revenue growth in the latter half of the period
  • Restrictions to trade and regulatory changes are likely to undermine future investment
  • Industry Report - Industry Key Buyers Chapter

    Industry concentration measures the extent to which the largest players dominate an industry. There has been an increase in the level of concentration in global pharmaceutical industries over the past five years because of escalating research and development costs, shorter exclusivity times and the need for global marketing power. The three largest companies in the industry were established through mergers, with the largest AstraZeneca UK Ltd, having undergone merger and acquisition activity during the past five years. Des...purchase to read more.

    Additional Insights for the Basic Pharmaceutical Product Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Basic Pharmaceutical Product Manufacturing Industry are

  • Having technology sharing arrangements with major players
  • Ability to alter goods and services produced in favour of market conditions
  • Effective cost controls
  • IBISWorld analysts also discuss how external factors such as Population aged 65 years and over and Total health expenditure in the Basic Pharmaceutical Product Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Basic Pharmaceutical Product Manufacturing Industry?

    Companies in the Basic Pharmaceutical Product Manufacturing industry manufacture medicinal active substances that are used for their pharmacological properties to make medications, including antibiotics, basic vitamins, salicylic acids and aspirin. The industry also includes companies that process blood and glands and manufacture chemically pure sugars.

    Industry Products
  • Human and animal blood processing
  • Chemically pure sugars
  • Active product ingredients
  • Industry Activities
  • Blood processing
  • Manufacturing medicinal active substances
  • Manufacturing chemically pure sugars
  • Processing glands and extracts from glands
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Population aged 65 years and over
  • Total health expenditure
  • Demand from pharmaceutical preparations manufacturing
  • Real effective exchange rate

  • Current Performance
  • Restructuring the industry
  • Export growth
  • Tightening regulations
  • Advancements and profitability
  • Generic competition
  • Chart: Revenue Growth

  • Industry Outlook
  • Industry Outlook continued
  • Restructuring and rationalisation
  • Threats and opportunities
  • Unhealthy margins
  • Table: Basic Pharmaceutical Product Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Basic Pharmaceutical Product Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Pharmaceutical Preparations Manufacturing
  • Hospitals
  • Biotechnology

  • Key Selling Industries
  • Inorganic Basic Chemical Manufacturing

  • Products & Services
  • Active product ingredients
  • Human and animal blood processing
  • Other
  • Chemically pure sugars
  • Chart: Basic Pharmaceutical Product Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
    Major Markets
  • Pharmaceutical preparations manufacturers
  • Hospitals
  • Other
  • Chart: Major Market Segmentation for the Basic Pharmaceutical Product Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    WagesPurchasesProfitDepreciationOther
  • Chart: Cost Structure Benchmarking – Sector vs Basic Pharmaceutical Product Manufacturing

  • Basis of Competition
    Internal competitionExternal competition
    Barriers to Entry
  • Table: Barrier to Entry Checklist for the Basic Pharmaceutical Product Manufacturing Industry

  • Industry Globalization
    Novartis UK Ltd, Glaxo Operations UK Ltd, AstraZeneca UK Ltd, Accord Healthcare Ltd,
  • Table: Novartis UK Ltd - financial performance
  • Table: Glaxo Operations UK Ltd - financial performance
  • Table: AstraZeneca UK Ltd - financial performance
  • Table: Accord Healthcare Ltd - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Basic Pharmaceutical Product Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Basic Pharmaceutical Product Manufacturing Industry
    Includes:
  • Industry Revenue (2011-2025)
  • Industry Gross Product (2011-2025)
  • Establishments (2011-2025)
  • Businesses (2011-2025)
  • Employment (2011-2025)
  • Exports (2011-2025)
  • Imports (2011-2025)
  • Wages (2011-2025)
  • Wages (2011-2025)
  • Purchases (2011-2025)
  • Profit (2011-2025)
  • Depreciation (2011-2025)
  • Marketing (2011-2025)
  • Rent (2011-2025)
  • Utilities (2011-2025)
  • Other (2011-2025)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Active Pharmaceutical Ingredient (Api)
  • The biologically active substance in a pharmaceutical drug.
  • Biopharmaceuticals
  • Pharmaceuticals derived from biological sources such as vaccines and stem cell therapies
  • Blockbuster Drug
  • An extremely popular drug that generates annual sales over $1 billion for the company that owns it
  • Boutique Drugs
  • Drugs that are either niche or produced in intentionally small numbers at very high prices.
  • Generic Drug
  • A drug with the same active ingredients as the patented original, but which is produced and distributed without patent protection.
  • Good Manufacturing Practice (Gmp)
  • A quality-control system for manufacturing active pharmaceutical ingredients and products.
  • What Our Customers Say

    Why buy this report?

    IBISWorld’s Basic Pharmaceutical Product Manufacturing market research report offers insightful industry analysis and research into the market at the national level. IBISWorld’s in-depth industry market research is presented in a logical and consistent format. The industry report contains key industry statistics, market size, industry trends, and growth and profit forecasts for a 5-year outlook period.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Basic Pharmaceutical Product Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Basic Pharmaceutical Product Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Basic Pharmaceutical Product Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Would you like to speak to an IBISWorld representative?

    clear